Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Lucy Shapiro, Louis Gerstner, Chamath Palihapitiya

Premium

Lucy Shapiro has been awarded the National Medal of Science. Shapiro is the Virginia and D.K. Ludwig professor of cancer research and director of the Beckman Center in the School of Medicine at Stanford University. She was a non-executive director of GlaxoSmithKline from 2001 to 2006 and is on the board of Gen-Probe and Pacific Biosciences. She is also a cofounder of Anacor Pharmaceuticals. She holds a BS from Brooklyn College and a PhD in molecular biology from the Albert Einstein School of Medicine.



Louis Gerstner
has been elected chairman of the Broad Institute's board of directors, succeeding outgoing chair Diana Chapman Walsh, who will continue to serve on the board as vice chair.

Gerstner was elected to the Broad's board in 2010. He was CEO and chairman of the board of IBM from 1993 to 2002 and has also served as chairman of the Carlyle Group and CEO of RJR Nabisco.


Chamath Palihapitiya has joined Syapse's board of directors as part of a Series A round of venture capital funding. Palihapitiya is a founder of Social Capital, which led the funding round.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.